These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [The relevance of biomarkers in acute heart failure]. Hellenkamp K; von Haehling S Internist (Berl); 2019 Jun; 60(6):587-596. PubMed ID: 31089771 [TBL] [Abstract][Full Text] [Related]
24. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides. Semenov AG; Feygina EE Adv Clin Chem; 2018; 85():1-30. PubMed ID: 29655458 [TBL] [Abstract][Full Text] [Related]
25. [Indications and Clinical Implications of the Use of the Cardiac Markers BNP and NT-proBNP]. Luchner A; von Haehling S; Holubarsch C; Keller T; Knebel F; Zugck C; Laufs U Dtsch Med Wochenschr; 2017 Mar; 142(5):346-355. PubMed ID: 28282683 [TBL] [Abstract][Full Text] [Related]
26. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
27. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Januzzi JL; Chen-Tournoux AA; Moe G Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855 [TBL] [Abstract][Full Text] [Related]
29. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides. Maisel AS; Duran JM; Wettersten N Heart Fail Clin; 2018 Jan; 14(1):13-25. PubMed ID: 29153197 [TBL] [Abstract][Full Text] [Related]
30. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. O'Hanlon R; O'Shea P; Ledwidge M; O'Loughlin C; Lange S; Conlon C; Phelan D; Cunningham S; McDonald K J Card Fail; 2007 Feb; 13(1):50-5. PubMed ID: 17339003 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis. Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664 [TBL] [Abstract][Full Text] [Related]
33. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship. Takase H; Dohi Y Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567 [TBL] [Abstract][Full Text] [Related]
34. Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure. Rosenberg J; Gustafsson F; Remme WJ; Riegger GA; Hildebrandt PR Cardiovasc Drugs Ther; 2008 Aug; 22(4):305-11. PubMed ID: 18309461 [TBL] [Abstract][Full Text] [Related]
35. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324 [TBL] [Abstract][Full Text] [Related]
36. [Natriuretic peptides--when should they be used in heart failure?]. Rottlaender D; Michels G; Hoppe UC Dtsch Med Wochenschr; 2008 Feb; 133(5):196-200. PubMed ID: 18213553 [TBL] [Abstract][Full Text] [Related]
37. Updating the role of natriuretic peptide levels in cardiovascular disease. Gopal DJ; Iqbal MN; Maisel A Postgrad Med; 2011 Nov; 123(6):102-13. PubMed ID: 22104459 [TBL] [Abstract][Full Text] [Related]